CVS executives knew that some of their sales would go up in smoke when they decided last year to stop selling cigarettes. The press release announcing that all 7,600 CVS stores nationwide would stop selling all tobacco products acknowledged that sales would take a hit. Still, the company said, “This is the right thing to do.”
The costs of the decision are now becoming clear. CVS Health’s general merchandise sales slumped 7.8 percent last quarter on a same-store basis, the company said Tuesday. The company claims non-pharmacy sales would have stayed the same if tobacco sales — and the other products cigarette buyers added to their baskets — were removed from sales figures for the same quarter in 2014.
Same-store sales in the pharmacy category climbed 4.1 percent, boosting overall same-store sales growth to 0.5 percent compared with the second quarter of last year, down from a 1.2 percent year-over-year increase the previous quarter. Net revenue overall grew by 7.4 percent to $37.2 billion, helped by pharmacy services revenue that surged 11.9 percent ($2.6 billion) to $24.4 billion. The company has reportedly increased its market share in the health and beauty categories (it did, however, narrow its full-year earnings forecast).
So even as the move to drop cigarettes has cost the company, its bet on health as the source of future growth may be starting to pay off. CVS stock dropped in the wake of its earnings announcement, but shares are still up more than 15 percent on the year and 44 percent over the past 12 months.
The Wall Street Journal reports that the tax cuts and economic environment are prompting U.S. companies to go on a buying binge: “Mergers and acquisitions announced by U.S. acquirers so far in 2018 are running at the highest dollar volume since the first two months of 2000, according to Dealogic. Thomson Reuters, which publishes slightly different numbers, puts it at the highest since the start of 2007.”
Health care spending in the U.S. will grow at an average annual rate of 5.5 percent from 2017 through 2026, according to new estimates published in Health Affairs by the Office of the Actuary at the Centers for Medicare and Medicaid Services (CMS).
The projections mean that health care spending would rise as a share of the economy from 17.9 percent in 2016 to 19.7 percent in 2026.
Margot Sanger-Katz and Jim Tankersley in The New York Times: “The deal struck by Democrats and Republicans on Monday to end a brief government shutdown contains $31 billion in tax cuts, including a temporary delay in implementing three health care-related taxes.”
“Those delays, which enjoy varying degrees of bipartisan support, are not offset by any spending cuts or tax increases, and thus will add to a federal budget deficit that is already projected to increase rapidly as last year’s mammoth new tax law takes effect.”
Congress passed a law in 2015 requiring the IRS to use private debt collection agencies to pursue “inactive tax receivables,” but the financial results are not encouraging so far, according to a new taxpayer advocate report out Wednesday.
In fiscal year 2017, the IRS received $6.7 million from taxpayers whose debts were assigned to private collection agencies, but the agencies were paid $20 million – “three times the amount collected,” the report helpfully points out.